FENNEC PHARMACEUTICALS INC. Stockholders Equity

Quick Answer

FENNEC PHARMACEUTICALS INC. reported Stockholders Equity of $35.47 million for fiscal year 2025.

FENNEC PHARMACEUTICALS INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $35.47M +704.1%
2024 -$5.87M +49.5%
2023 -$11.62M -221.3%
2023 $9.58M +472.9%
2022 -$2.57M -116.3%
2021 $15.77M -45.7%
2020 $29.07M +144.8%
2019 $11.88M -44.3%
2018 $21.31M -20.3%
2017 $26.76M +649.5%
2016 $3.57M +551.5%
2015 $548.0K -10.6%
2014 $613.0K +142.1%
2013 -$1.46M +70.6%
2012 -$4.96M -4065.5%
2011 -$119.0K +97.6%
2010 -$4.92M -1313.1%
2009 $406.0K -86.7%
2008 $3.05M -78.4%
2007 $14.15M +1015.8%
2006 $1.27M -88.6%
2005 $11.08M -33.5%
2004 $16.65M -18.6%
2004 $20.45M +2830.4%
2003 $698.0K -88.5%
2002 $6.07M -38.0%
2001 $9.79M +20734.0%
2000 $47.0K -80.6%
1999 $242.0K +155.6%
1998 -$435.0K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$4.49M +13.1% +39.8%
June 30, 2025 -$7.46M -450.0% -26.9%
March 31, 2025 -$5.88M -295.1% -0.1%
December 31, 2024 -$5.87M +49.5% -13.6%
September 30, 2024 -$5.17M +50.9% -281.1%
June 30, 2024 -$1.36M +86.0% -145.0%
March 31, 2024 $3.01M +141.1% +125.9%
December 31, 2023 -$11.62M -352.4% -10.4%
  • FENNEC PHARMACEUTICALS INC. showed an increase of +704.1% in Stockholders Equity compared to the prior fiscal year.
  • Over the 1998–2025 period, FENNEC PHARMACEUTICALS INC.’s stockholders equity has grown by 8254.5% (from -$435.0 thousand to $35.47 million).
  • The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment